Cite

    B. El Osta et al.. “Not all immune-checkpoint inhibitors are created equal: Meta-analysis and systematic review of immune-related adverse events in cancer trials.” Critical reviews in oncology/hematology, vol. 119, 2017, pp. 1–12. http://access.bl.uk/ark:/81055/vdc_100051530703.0x000037